Virax Biolabs VRAX
NASDAQ VRAX
$1.36 -0.01 (-0.73%)
As of: Oct 21, 2026 · 12:53 PM EDT

Virax Biolabs (VRAX) Common Equity (2021 - 2026)

Updated

Virax Biolabs' Common Equity was -$310,278 in fiscal Q4 2026 (quarter ended Mar 31, 2026), compared with $112,330 a year earlier.

Analysis

Virax Biolabs (VRAX) Common Equity (2021 - 2026) Analysis & Trends

From fiscal Q4 2021 onward, Virax Biolabs has reported Common Equity for 10 quarters.

  • In earlier fiscal years, Common Equity was $112,330 in FY2025 (-97.8%), $5.14 million in FY2024 (-42.3%), $8.9 million in FY2023 and -$1.2 million in FY2022.
  • The fiscal Q4 2026 figure marks the lowest quarterly Common Equity since fiscal Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Thermo Fisher Scientific 258.70 Bn 237.73 Bn 4.88 Bn 52.69 Bn
2 Abbott Laboratories 171.57 Bn 142.00 Bn 7.27 Bn 51.76 Bn
3 Danaher 162.29 Bn 146.10 Bn 3.61 Bn 52.59 Bn
4 Intuitive Surgical 150.18 Bn 129.60 Bn 1.96 Bn 18.30 Bn
5 Medtronic 119.47 Bn 84.72 Bn 6.34 Bn 50.85 Bn
6 Stryker 113.91 Bn 100.03 Bn 4.50 Bn 23.99 Bn
7 Boston Scientific 65.30 Bn 60.07 Bn 3.85 Bn 25.17 Bn
8 Becton Dickinson 53.51 Bn 50.66 Bn 2.32 Bn 24.42 Bn
9 Edwards Lifesciences 50.73 Bn 34.74 Bn 1.35 Bn 10.72 Bn
10 Virax Biolabs 540,722.41 -20.76 Mn - 7.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 7.58 Mn
Sep 30, 2025 5.31 Mn
Mar 31, 2025 5.70 Mn
Sep 30, 2024 8.64 Mn
Mar 31, 2024 5.14 Mn
Sep 30, 2023 6.33 Mn
Mar 31, 2023 8.90 Mn
Sep 30, 2022 12.17 Mn
Mar 31, 2022 -1.20 Mn
Mar 31, 2021 -831,814.00
API Access

Virax Biolabs Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=VRAX&period=max&api_key=YOUR_API_KEY